| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2013 | WO2012158784A3 Modulators of the nuclear hormone receptor ror |
| 01/03/2013 | WO2012155226A8 Method for producing pyrostegia venusta derivatives, pyrostegia venusta derivatives, pharmaceutical compositions and uses thereof |
| 01/03/2013 | WO2012154942A3 Ceramide anionic liposome compositions |
| 01/03/2013 | WO2012154627A3 Light delivery device and related compositions, methods and systems |
| 01/03/2013 | WO2012153347A3 Oral pharmaceutical composition of olanzapine form 1 and sodium starch glycolate |
| 01/03/2013 | WO2012152940A3 Small molecule inhibitors of trpa1 |
| 01/03/2013 | WO2012151141A3 A facile preparation of 4-substituted quinazolines and related heterocycles |
| 01/03/2013 | WO2012150839A3 Method for microencapsulating phosphatidylserine |
| 01/03/2013 | WO2012150784A3 Novel indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient |
| 01/03/2013 | WO2012149546A3 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy |
| 01/03/2013 | WO2012149472A9 Methods, compositions, and kits for treating and preventing neurological conditions |
| 01/03/2013 | WO2012149335A3 Small molecule inhibitors of rgs proteins |
| 01/03/2013 | WO2012149255A3 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins |
| 01/03/2013 | WO2012149247A3 Tolerogenic synthetic nanocarrier compositions with transplantable graft antigens and methods of use |
| 01/03/2013 | WO2012149218A3 Antagonists of trpv1 receptor |
| 01/03/2013 | WO2012149186A3 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use |
| 01/03/2013 | WO2012148148A3 Novel zinc azide complex and a process for preparing tetrazole derivatives using the same |
| 01/03/2013 | WO2012148140A3 Imidazole-based alkaloid derivatives which have angiogenesis inhibition and antioxidant effects and production method thereof |
| 01/03/2013 | WO2012142520A3 Unit dose form for oral administration |
| 01/03/2013 | WO2012141536A9 Composition for regenerating connective tissue, and method for regenerating connective tissue |
| 01/03/2013 | WO2012141502A3 Controlled release type tablet containing aceclofenac |
| 01/03/2013 | WO2012140666A3 Herbal extracts and compositions prepared therefrom |
| 01/03/2013 | WO2012138715A3 Small molecule inhibitors of xbp1 splicing |
| 01/03/2013 | WO2012137227A3 Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof |
| 01/03/2013 | WO2012136969A3 Ophthalmic treatments |
| 01/03/2013 | WO2012136356A8 6,7-diydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation |
| 01/03/2013 | WO2012135615A3 Enopeptins, uses thereof, and methods of synthesis thereto |
| 01/03/2013 | WO2012135296A3 Imidazolyl amide compounds and uses related thereto |
| 01/03/2013 | WO2012135149A3 Small molecule modulators of sirt1 activity activate p53 and suppress tumor growth |
| 01/03/2013 | WO2012135027A3 Thiolactone antibiotics |
| 01/03/2013 | WO2012134234A3 Use of hades as a negative modulator of akt |
| 01/03/2013 | WO2012134231A9 Benzamide derivative as cannabinoid receptor (cb1) antagonist |
| 01/03/2013 | WO2012134126A3 Use of compounds isolated from morus bark |
| 01/03/2013 | WO2012129394A3 Methods and compositions for the treatment of cancer |
| 01/03/2013 | WO2012128576A3 Composition for treating lower or damaged cognitive function containing dehydroglyasperin c typically found in licorice |
| 01/03/2013 | WO2012128521A3 Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor |
| 01/03/2013 | WO2012123561A3 Agent for prophylaxis and treatment of age-associated diseases and disorders and for prolonging life |
| 01/03/2013 | WO2012122471A3 Compounds and methods of use in ablative radiotherapy |
| 01/03/2013 | WO2012119019A3 Method of extracting phenolic fractions of extra virgin olive oil |
| 01/03/2013 | WO2012112953A3 Molecular switch for neuronal outgrowth |
| 01/03/2013 | WO2012107735A3 Treatment of bipolar disorder |
| 01/03/2013 | WO2012104576A3 Carotenoid particles and uses thereof |
| 01/03/2013 | WO2012093258A3 Irf5- related treatment and screening |
| 01/03/2013 | WO2012088491A3 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same |
| 01/03/2013 | WO2012062905A3 Chromene derivatives and their analoga as wnt pathway antagonists |
| 01/03/2013 | WO2009125226A8 Pharmaceutical depot comprising n-{5-[(cyclopropylamino)carbonyl] -2-methylphenyl}-3-fluoro-4- (pyridin-2-ylmethoxy)benzamide |
| 01/03/2013 | WO2009093144A3 Photodynamic therapy for the treatment of sebaceous gland disorders |
| 01/03/2013 | US20130006351 Polymer coatings containing drug powder of controlled morphology |
| 01/03/2013 | US20130006350 Drug-delivery endovascular stent and method for treating restenosis |
| 01/03/2013 | US20130006182 Pharmaceutical compositions |
| 01/03/2013 | US20130005977 Oxycodone Hydrochloride Having Less Than 25 PPM 14-Hydroxycodeinone |
| 01/03/2013 | US20130005830 Sandalwood oil and its uses |
| 01/03/2013 | US20130005829 Segmented, epsilon-Caprolactone-Rich, Poly(epsilon-Caprolactone-co-p-Dioxanone) Copolymers for Medical Applications and Devices Therefrom |
| 01/03/2013 | US20130005828 Composition and method to alleviate joint pain |
| 01/03/2013 | US20130005827 Inhibition of the Survival of Bladder Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/03/2013 | US20130005826 Inhibition of the Survival of Gastric Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/03/2013 | US20130005825 Inhibition of the Survival of Lymphoma by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/03/2013 | US20130005824 Treatment of ischemic tissue |
| 01/03/2013 | US20130005823 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 01/03/2013 | US20130005822 Aerosolized dapsone as a therapy for inflammation of the airway and abnormal mucociliary transport |
| 01/03/2013 | US20130005821 Intravenous administration of tramadol |
| 01/03/2013 | US20130005820 Agomelatine hydrochloride hydrate and preparation thereof |
| 01/03/2013 | US20130005818 Glycogen or Polysaccharide Storage Disease Treatment Method |
| 01/03/2013 | US20130005817 Ketoprofen-Containing Aqueous Adhesive Skin Patch |
| 01/03/2013 | US20130005816 Transdermal compositions of ibuprofen and methods of use thereof |
| 01/03/2013 | US20130005815 Aqueous intraocular penetration-promoting eye drop |
| 01/03/2013 | US20130005814 Methods and compositions for facilitating weight loss by administration of thyroid hormones |
| 01/03/2013 | US20130005813 Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field |
| 01/03/2013 | US20130005812 Method for alleviating allergic asthma and allergic response by using bitter melon composition |
| 01/03/2013 | US20130005809 Methods of treating hypertriglyceridemia |
| 01/03/2013 | US20130005806 Analysis of tmlhe and carnitine biosynthesis for autism diagnosis |
| 01/03/2013 | US20130005805 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | US20130005804 Novel Uses of Neuraminidase Inhibitors in Infectious Diseases |
| 01/03/2013 | US20130005803 Use of compounds in the treatment or prevention of skin disorders |
| 01/03/2013 | US20130005802 Treatment of wnt/frizzled-related diseases |
| 01/03/2013 | US20130005801 Phenylcarbamate compound and muscle relaxant containing the same |
| 01/03/2013 | US20130005800 Composition for transdermal or transmucosal administration |
| 01/03/2013 | US20130005799 The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas |
| 01/03/2013 | US20130005798 Antiprotozoal compound derived from coelenterata |
| 01/03/2013 | US20130005796 Method for proliferating cardiomyocytes using micro-rna |
| 01/03/2013 | US20130005795 Use of Light Sensitive Genes |
| 01/03/2013 | US20130005794 Methods and sequences to suppress primate huntington gene expression |
| 01/03/2013 | US20130005793 Compositions and Methods for Inhibiting Gene Expression of Hepatitis B Virus |
| 01/03/2013 | US20130005792 Biomarkers to identify hiv-specific t-cell subsets |
| 01/03/2013 | US20130005791 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF |
| 01/03/2013 | US20130005790 Inorganic salt complexes of vildagliptin |
| 01/03/2013 | US20130005789 Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes |
| 01/03/2013 | US20130005788 Anti-francisella agents |
| 01/03/2013 | US20130005787 High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
| 01/03/2013 | US20130005786 Therapeutic invention |
| 01/03/2013 | US20130005785 Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations |
| 01/03/2013 | US20130005784 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 01/03/2013 | US20130005783 Prevention And Treatment Of Diseases Caused By Elevated Levels Of Deoxy-Sphingolipids |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005781 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 01/03/2013 | US20130005780 Controlled release pharmaceutical compositions of tapentadol |
| 01/03/2013 | US20130005779 Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics |
| 01/03/2013 | US20130005778 Urethanes, ureas, amidines and related inhibitors of factor xa |
| 01/03/2013 | US20130005777 Sorafenib ethylsulfonate salt, process for preparation and use |
| 01/03/2013 | US20130005776 Metalloenzyme inhibitor compounds |